The United States has imposed sanctions on a China-based network involved in the production and distribution of illicit drugs, including fentanyl, methamphetamine, and MDMA precursors. The U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) has designated 28 individuals and entities connected to this international drug trafficking network.
The sanctioned individuals and entities are also engaged in the global trafficking of highly potent substances like xylazine and nitazenes, which are often mixed with illicit fentanyl or other drugs.
Deputy Secretary of the Treasury, Wally Adeyemo, emphasized the decisive action being taken to disrupt a network responsible for manufacturing and distributing drugs that have led to thousands of American deaths each year. The sanctions target entities and individuals in both China and Canada.
Various U.S. agencies, including the Internal Revenue Service, Criminal Investigations, the Financial Crimes Enforcement Network, the Drug Enforcement Administration (DEA), and the Department of Homeland Security’s U.S. Customs and Border Protection agency, were involved in this action.
Fentanyl is a powerful synthetic opioid associated with a significant increase in opioid-related overdose deaths in various countries, including the United States. The Treasury Department’s move highlights the importance of coordination among authorities in investigating precursor supply chains and disrupting the financial flows of illicit drug proceeds, as recommended in the Financial Action Task Force’s 2022 report on Money Laundering from Fentanyl and Synthetic Opioids.
This action follows a series of financial sanctions targeting the illicit fentanyl supply chain, including actions against those facilitating counterfeit pill production in China and Mexico.
By FCCT Editorial Team freeslots dinogame telegram营销